The human spirit has the ability to face the uncertainty of the future with curiosity and optimism. It is the belief that problems can be solved, differences resolved. It is a type of confidence and it is fragile. One may further elucidate that there are two sides to any coin. So, whether or not you should go ahead with one decision always has a 50% chance of turning out correct. This forms a crucial element in doubt and uncertainty. You are always unsure of what is right and wrong, but taking the risk is the only way. It was once said, "You cannot be certain about uncertainty." To define it any other way would be quite difficult.
Thus, Britain deciding to leave the European Union in June, the election of Donald Trump as the 45 th President of the United States in a bitterly fought campaign and, last, but not least, to a lesser extent, the demonetisation in India of currency notes of denominations RS 500.00 and RS 1000.00 (approx. 85% of the circulating currency) may seem like introducing uncertainty; however, being apolitical, the view is purely to assess the impact on science, education and research.
Cardiovascular disease remains the number one cause of death globally and, with an ever-aging population, will continue to cause a significant burden and cost of disease. Research often faces the barriers of data integration, public awareness and involvement, lack of coordination between various entities and cumbersome application processes. According to the health funding analysis from the UK Clinical Research Collaboration, funding for cardiovascular disease significantly lags behind funding for cancer, infection and neurological disorders and is on a par with mental health research; with the vast majority of funding coming from charitable sources.
In the United States, cardiovascular research is better funded, probably because of a myriad of funding sources from hospital charities, national societies, greater coordination with industry and more resources available from the National Institutes of Health. In 2016, the American Heart Association, in collaboration with industry, launched the One Brave Idea initiative as a single research vision for ending coronary heart disease. It remains to be seen whether this model and calls for improving disease prevention will be embraced by the incoming administration. As the UK contemplates life post-Brexit, we hope this example of scientific collaboration and funding model inspires us to seek new ways to continue and propagate further cutting-edge research.
It has to be emphasised that investment in education, research and science can only have unparalleled returns and decision makers and leaders must be encouraged to not only maintain, but contradictorily increase resources and funding to ensure better health.
Perfusion remains at the forefront Worldwide and I am pleased that authors such as Ranucci, Mongero, Simons, Romagnoli and others actively maintain their enthusiasm to conduct science and pursue publication. 
